214
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women

, , , &
Pages 465-471 | Received 22 Nov 2013, Accepted 05 Jan 2014, Published online: 11 Feb 2014

References

  • Kowdley KV, Caldwell S. Nonalcoholic steatohepatitis. A twenty-first century epidemic. J Clin Gastroenterol 2006;40:S2–4
  • Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006;4:S5–10
  • Suzuki A, Abdemalek F. Nonalcoholic fatty liver disease in women. Women's Health 2009;5:1–13
  • Torres DM, Williams CD, Harrison SA. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012;10:837–58
  • Loria P, Adinolfi LE, Bellentani S, et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010;42:272–82
  • Caballeria L, Auladell MA, Torán P, et al. Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study. BMC Gastroenterol 2008;8:44–50
  • Sowers MF, Zheng H, Tomey K, et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab 2007;92:895–901
  • Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 2004;5:197–216
  • Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality. Sixteen years of follow-up in US women. Circulation 2008;117:1658–67
  • Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005;42: 987–1000
  • Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. Q J Med 2010;103:71–83
  • Hamguchi M, Kojima T, Ohbora A, Takeda Nm Fukui N, Kato T. Aging is a risk factor of non alcoholic fatty liver disease in pre-menopausal women. World J Gastroenterol 2012;18:237–43
  • Gutierrez-Grobe Y, Ponciano-Rodriguez G, Ramos MH, Uribe M, Mendez-Sanchez N. Prevalence of non alcoholic fatty liver disease in premenopausal, postmenopausal and polycystic ovary syndrome women. The role of estrogen. Ann Hepatol 2010; 9:402–9
  • NCEP Expert Panel on the detection, evaluation, and treatment of high blood pressure in adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). Adult Treatment Panel III (ATP III). JAMA 2001;285:2444–9
  • Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN. The threshold value for insulin resistance (HOMA-IR) in an admixture population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 2006;72:219–20
  • Tchelepi H, Ralls PW, Radin R, Grant E. Sonography of diffuse liver disease. J Ultrasound Med 2002;21:1023–32
  • Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterol 2005;129:113–21
  • Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124–31
  • Volzke H, Schwarz S, Baumeister SE, et al. Menopausal status and hepatic steatosis in a general female population. Gut 2007; 56:594–5
  • Shimizu I, Ito S. Protection of estrogens against the progression of chronic liver disease. Hepatol Res 2007;37:239–47
  • Tardivo AP, Nahas-Neto J, Nahas EAP, Maesta N, Rodrigues MH, Orsatti FL. Associations between healthy eating patterns and indicators of metabolic risk in postmenopausal women. Nutr J 2010;9:64
  • Nahas EAP, Padoani NP, Nahas-Neto J, Orsatti FL, Tardivo AP, Dias R. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women. Climacteric 2009;12:431–8
  • Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis and the metabolic syndrome. Hepatology 2003;37:917–23
  • McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 2006;40:S17–29
  • Petta S, Muratore C, Craxì A. Non-alcoholic fatty liver disease pathogenesis: The present and the future. Dig Liver Dis 2009;41:615–25
  • Caballerıa L, Pera G, Rodriguez L, Auladell MA, Bernard J, Toran SC. Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population: influence of the diagnostic criteria used. Eur J Gastroenterol Hepatol 2012;24:1007–11
  • Dowman JK, Tomlinson JW, Newsome JW. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2011;33: 525–40
  • IBGE. POF (Pesquisa de Orçamentos Familiares) 2008–2009. http://www.ibge.gov.br/home/presidencia/noticias/ accessed on September 26th, 2013
  • Strauss S, Gavish E, Gottlieb P, Katsnelson L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. Am J Roentgenol 2007;189:W320–3
  • Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Clark JM. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011;54:1082–90

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.